Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-27

FDA Approved: RASAGILINE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved Chartwell RX, LLC's original application for a generic rasagiline product (Rasagiline). Rasagiline is used in the treatment of Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RASAGILINE (rasagiline)

Snippet

ORIG AP for RASAGILINE (RASAGILINE)